Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells. (2019)
Attributed to:
Targeting the FOXM1 signature for early diagnosis and treatment in cholangiocarcinoma
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41388-019-0890-7
PubMed Identifier: 31312024
Publication URI: http://europepmc.org/abstract/MED/31312024
Type: Journal Article/Review
Volume: 38
Parent Publication: Oncogene
Issue: 36
ISSN: 0950-9232